Advertisement

Pediatric Cardiology

, Volume 40, Issue 3, pp 610–615 | Cite as

Transcatheter Closure of Atrial Septal Defects: Comparable Experience and Outcomes Between Developing and Developed Countries

  • Ahmad Almanla
  • Fatme Charafeddine
  • Mohamad Abutaqa
  • Hala Mustafa
  • Anas Tabbakh
  • Haytham Bou Hussein
  • Fadi Sawaya
  • Issam El-Rassi
  • Mariam Arabi
  • Ziad Bulbul
  • Fadi BitarEmail author
Original Article
  • 83 Downloads

Abstract

Atrial septal defect (ASD) is one of the most common congenital heart defects. Transcatheter device closure of ASDs is safe and effective with most of the reported data being described from developed countries. To evaluate the short and mid-term results and experience of device closure of ASDs at a tertiary center in a developing country and compare it to that from developed countries. Retrospective study based on data collection from all patients who have undergone transcatheter percutaneous device closure for ASD from January 2005 until December 2017 at the Children’s Heart Center at the American University of Beirut, Medical Center, Lebanon. During the study period, a total of 254 cardiac catheterizations were performed for device closure of ASDs. The mean age of the patients was 18 ± 17.9 years with 37% being less than 6 years of age. Females were 54%. Defect size ranged from 7 to 37 mm and device size ranged from 8 to 40 mm. The procedure was executed with a success rate of 96%. Five patients had device embolization (2%); in one patient the device was snared and for the remainder the devices were removed surgically. None of the study patients had thrombus formation, neurological complications, bacterial endocarditis, or cardiac erosions. There was no mortality. Device closure of ASDs at our tertiary center in a developing country has an effective and safe profile with excellent results and low complications rates, which compare favorably to those reported from centers in developed countries.

Keywords

Atrial septal defect Transcatheter closure Success rate Complications Developing and developed countries 

Notes

Funding

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest related with the manuscript and the study is not supported by any grant or institution.

Ethical Approval

The study was performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the Institutional Review Board at the American University of Beirut – Medical Center.

References

  1. 1.
    Webb G, Gatzoulis MA (2006) Atrial septal defects in the adult: recent progress and overview. Circulation 114(15):1645–1653CrossRefGoogle Scholar
  2. 2.
    King TD et al (1976) Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 235(23):2506–2509CrossRefGoogle Scholar
  3. 3.
    Moore J et al (2013) Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv 6(5):433–442CrossRefGoogle Scholar
  4. 4.
    Jones TK, Latson LA, Zahn E, Fleishman CE, Jacobson J, Vincent R et al (2007) Results of the US multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects. J Am Coll Cardiol 49:2215–2221CrossRefGoogle Scholar
  5. 5.
    Pac A, Polat TB, Cetin I, Oflaz MB, Balli S (2009) Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects. J Interv Cardiol 22(6):489–495.  https://doi.org/10.1111/j.1540-8183.2009.00497.x CrossRefGoogle Scholar
  6. 6.
    Roymanee S et al (2015) Comparison of the Occlutech (R) Figulla (R) septal occluder and Amplatzer (R) septal occluder for atrial septal defect device closure. Pediatr Cardiol 36(5):935–941CrossRefGoogle Scholar
  7. 7.
    Aytemir K et al (2012) Early-midterm follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience. J Interv Cardiol 25(4):375–381CrossRefGoogle Scholar
  8. 8.
    Feltes TF, Bacha E, Beekmand RH 3rd, Cheatham JP, Feinstein JA, Gomes AS et al (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 123:2607–2652CrossRefGoogle Scholar
  9. 9.
    Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N et al (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31:2915–2957CrossRefGoogle Scholar
  10. 10.
    Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Amplatzer Investigators (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39(11):1836–1844CrossRefGoogle Scholar
  11. 11.
    Moake L, Ndinjiakat SK (2011) Transcatheter device closure for atrial septal defects: safety, efficacy, complications, and costs. Crit Care Nurs Clin North Am 23(2):339–348CrossRefGoogle Scholar
  12. 12.
    Kefer J et al (2012) Percutaneous transcatheter closure of interatrial septal defect in adults: procedural outcome and long-term results. Catheter Cardiovasc Interv 79(2):322–330CrossRefGoogle Scholar
  13. 13.
    Fiarresga A et al (2010) Percutaneous closure of atrial septal defects: a decade of experience at a reference center. Rev Port Cardiol 29(5):767–780Google Scholar
  14. 14.
    El-Said H, Hegde S, Foerster S, Hellenbrand W, Kreutzer J, Trucco SM, Holzer R, Burch G, Mirani A, Nicolas R, Porras D, Bergersen L, Moore J (2015) Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv 85(2):227–233.  https://doi.org/10.1002/ccd.25684 CrossRefGoogle Scholar
  15. 15.
    Everett AD, Jennings J, Sibinga E, Owada C, Lim DS, Cheatham J, Holzer R, Ringewald J, Bandisode R, Ringel R (2009) Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol 30(3):240–247.  https://doi.org/10.1007/s00246-008-9325-x CrossRefGoogle Scholar
  16. 16.
    Moore JW, Vincent RN, Beekman RH 3rd, Benson L, Bergersen L, Holzer R, Jayaram N, Jenkins K, Li Y, Ringel R, Rome J, Martin GR, NCDR IMPACT Steering Committee (2014) Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry. J Am Coll Cardiol 64(23):2439–2451.  https://doi.org/10.1016/j.jacc.2014.09.045 CrossRefGoogle Scholar
  17. 17.
    Clem A, Awadallah S, Amin Z (2017) Safety, Feasibility, results, and economic impact of common interventional procedures in a low-volume region of the United States. Pediatr Cardiol 38(7):1332–1336.  https://doi.org/10.1007/s00246-017-1664-z CrossRefGoogle Scholar
  18. 18.
    Chessa M et al (2002) Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 39(6):1061–1065CrossRefGoogle Scholar
  19. 19.
    Ali SH, El Sisi A, Raafat DM, Amry SE, Mahamoud SED (2018) Short-term outcomes of transcatheter closure of secundum atrial septal defect in children and adolescents: an experience of two centers in Upper Egypt. J Saudi Heart Assoc 30(1):14–20.  https://doi.org/10.1016/j.jsha.2017.04.004 CrossRefGoogle Scholar
  20. 20.
    Putra ST, Djer MM, Idris NS, Samion H, Sastroasmoro S (2015) Transcatheter closure of atrial septal defects in a center with limited resources: outcomes and short term follow-up. Iran J Pediatr 25:e3906CrossRefGoogle Scholar
  21. 21.
    Ali M, Salah El-Din H, Bakhoum S, El-Sisi A, Mahmood K, Farouk H, Kandil H (2018) Feasibility of percutaneous closure of atrial septal defects in adults under transthoracic echocardiography guidance using the Figulla atrial septal defect occluder device. J Saudi Heart Assoc 30(1):21–27.  https://doi.org/10.1016/j.jsha.2017.04.002 CrossRefGoogle Scholar
  22. 22.
    Quek SC et al (2010) Transcatheter closure of atrial septal defects–is balloon sizing still necessary? Ann Acad Med Singapore 39(5):390–393Google Scholar
  23. 23.
    Cilingiroglu M, Salinger M, Zhao D, Feldman T (2011) Technique of temporary subcutaneous “Figure-of-Eight” sutures to achieve hemostasis after removal of large-caliber femoral venous sheaths. Catheter Cardiovasc Interv 78(1):155–160.  https://doi.org/10.1002/ccd.22946 CrossRefGoogle Scholar
  24. 24.
    Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster S et al (2010) Adverse event rates in congenital cardiac catheterization – a multi-center experience. Catheter Cardiovasc Interv 75:389–400Google Scholar
  25. 25.
    Bergersen L, Gauvreau K, Foerster SR, Marshall AC, McElhinney DB, Beekman RH et al (2011) Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv 4:1037–1046CrossRefGoogle Scholar
  26. 26.
    Mulukutla V, Qureshi AM, Pignatelli R, Ing FF (2017) Predictive factors for patients undergoing ASD device occlusion who “crossover” to surgery. Pediatr Cardiol.  https://doi.org/10.1007/s00246-017-1771-x Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ahmad Almanla
    • 1
  • Fatme Charafeddine
    • 1
    • 2
  • Mohamad Abutaqa
    • 1
    • 2
  • Hala Mustafa
    • 1
  • Anas Tabbakh
    • 1
    • 2
  • Haytham Bou Hussein
    • 1
    • 2
  • Fadi Sawaya
    • 3
  • Issam El-Rassi
    • 2
  • Mariam Arabi
    • 1
    • 2
  • Ziad Bulbul
    • 1
    • 2
  • Fadi Bitar
    • 1
    • 2
    • 4
    Email author
  1. 1.Department of Pediatrics and Adolescent MedicineAmerican University of Beirut Medical Center (AUBMC)BeirutLebanon
  2. 2.Children’s Heart CenterAUBMCBeirutLebanon
  3. 3.Cardiology DivisionAUBMCBeirutLebanon
  4. 4.Children’s Heart Center, Department of Pediatrics and Adolescent MedicineAmerican University of BeirutRiad El Solh, BeirutLebanon

Personalised recommendations